DELINEATION OF SPATIAL TISSUE SIGNATURES OF IMMUNOTHERAPY RESPONSE GROUPS IN NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Kulasinghe, Arutha [1 ]
Monkman, James [1 ]
Kim, Honesty [2 ]
Mayer, Aaron [2 ]
Mehdi, Ahmed [1 ]
Cumberbatch, Marie [3 ]
Bhagat, Milan [3 ]
Schneider, Fabian [4 ]
Thaagard, Jeppe [4 ]
Mansfield, James [4 ]
Ladwa, Rahul [5 ]
Mueller, Scott [6 ]
Adams, Mark [7 ]
O'byrne, Kenneth [5 ]
机构：
[1] Univ Queensland, Brisbane, Qld, Australia
[2] Enable Med, Menlo Pk, CA USA
[3] Tristar Technol, London, DC, England
[4] Visiopharm, Horsholm, Denmark
[5] Princess Alexandra Hosp, Brisbane, Qld, Australia
[6] Univ Melbourne, Melbourne, Vic, Australia
[7] Queensland Univ Technol, Brisbane, Qld, Australia
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0118
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
118
引用
收藏
页码：A130 / A130
页数：1
相关论文
共 50 条
  • [41] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Gemcitabine in non-small cell lung cancer (NSCLC)
    Manegold, C
    Zatloukal, P
    Krejcy, K
    Blatter, J
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 29 - 42
  • [44] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [45] Immune Signatures of Non-Small Cell Lung Cancer
    Green, Susan
    Dawe, David E.
    Banerji, Shantanu
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (06) : 913 - 915
  • [46] Evaluating Genomic Signatures Predicting Veliparib Sensitivity in Non-Small Cell Lung Cancer (NSCLC)
    He, Lei
    Huang, Xin
    Sun, Yan
    Sehgal, Vasudha
    Lu, Xin
    Jiang, Fang
    Jung, Paul
    Deng, Youping
    Palma, Joann
    Bhathena, Anahita
    Ansell, Peter
    Mckee, Mark
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S267 - S268
  • [47] Biomarkers of immunotherapy for non-small cell lung cancer
    Shirasawa, Masayuki
    Yoshida, Tatsuya
    Ohe, Yuichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (01) : 13 - 22
  • [48] Perioperative Immunotherapy in Non-Small Cell Lung Cancer
    Jenny O’Brien
    J. Nicholas Bodor
    Current Treatment Options in Oncology, 2023, 24 : 1790 - 1801
  • [49] Principles of Immunotherapy in Non-Small Cell Lung Cancer
    Hsu, Melinda L.
    Naidoo, Jarushka
    THORACIC SURGERY CLINICS, 2020, 30 (02) : 187 - +
  • [50] Combination Immunotherapy in Non-small Cell Lung Cancer
    Melina E. Marmarelis
    Charu Aggarwal
    Current Oncology Reports, 2018, 20
12345